-
37
- Sun, Y., Zou, H., Yang, L., Zhou, M., Shi, X., Yang, Y., . . . Lu, Y. (2018). Effect on the liver cancer cell invasion ability by studying the associations between autophagy and TRAP1 expression.?Oncology Letters.
- doi:10.3892/ol.2018.8774
-
38
- Zhang, H., Zhang, Z., Jia, L., Ji, W., & Li, H. (2018). Genetic Polymorphism in the RYR1 C6487T Is Associated with Severity of Hypospadias in Chinese Han Children.?BioMed Research International, 2018, 1-7.
- doi:10.1155/2018/7397839
-
39
- Wang, J., Wang, F., Zhu, J., Song, M., An, J., & Li, W. (2018). Transcriptome Profiling Reveals PHLDA1 as a Novel Molecular Marker for Ischemic Cardiomyopathy.?Journal of Molecular Neuroscience,65(1), 102-109.
- doi:10.1007/s12031-018-1066-6
-
40
- Zhang, Y., Pan, C., Wang, J., Cao, J., Liu, Y., Wang, Y., & Zhang, L. (2017). Genetic and immune features of resectable malignant brainstem gliomas.?Oncotarget,8(47).
- doi:10.18632/oncotarget.19653
-
41
- Zhang, Z., Liu, Y., Liu, P., Yang, L., Jiang, X., Luo, D., & Yang, D. (2017). Non-invasive detection of gastric cancer relevant d-amino acids with luminescent DNA/silver nanoclusters.?Nanoscale,9(48), 19367-19373.
- doi:10.1039/c7nr07337b
-
42
- Yu, D., Ye, T., Xiang, Y., Shi, Z., Zhang, J., Lou, B., . . . Zhou, M. (2017). Quercetin inhibits epithelial–mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial–mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells.?OncoTargets and Therapy,Volume 10, 4719-4729.
- doi:10.2147/ott.s136840
-
43
- Wang, J., Huang, J., Wang, L., Chen, C., Yang, D., Jin, M., . . . Song, Y. (2017). Urban particulate matter triggers lung inflammation via the ROS-MAPK-NF-κB signaling pathway.?Journal of Thoracic Disease,9(11), 4398-4412.
- doi:10.21037/jtd.2017.09.135
-
44
- Wang, Q., Wang, Y., Xing, Y., Yan, Y., Guo, P., Zhuang, J., . . . Zhang, J. (2016). Physcion 8- O -β-glucopyranoside induces apoptosis, suppresses invasion and inhibits epithelial to mesenchymal transition of hepatocellular carcinoma HepG2 cells.?Biomedicine & Pharmacotherapy,83, 372-380.
- doi:10.1016/j.biopha.2016.06.045